Jason Summa

Jason Summa currently serves as Senior Director of Medical Monitoring at TORL Biotherapeutics, LLC, where responsibilities include providing clinical and strategic oversight for oncology programs. Prior to this role, Jason Summa was a consultant at Summa Consulting Group, focusing on global regulatory and clinical documentation for biopharma clients. As Vice President of Clinical Development and Operations at Phosplatin Therapeutics, Jason Summa led the design and execution of oncology trials. Jason Summa's experience with oncology programs continued at The Janssen Pharmaceutical Companies of Johnson & Johnson, directing global programs through Phase II–III development. Earlier in the career, Jason Summa contributed to clinical development and operations in oncology at BIND Therapeutics. Jason Summa holds an MBA from the Questrom School of Business at Boston University and a BS in Chemistry from Penn State University.